1. |
Roshanali F,Mandegar MH,Yousefnia MA,et al.Prevention of atrial fibrillation after coronary artery bypass grafting via atrial electromechanical interval and use of amiodarone prophylaxis.Interact CardioVasc Thorac Surg,2009,8(4):421-425.
|
2. |
Ma CS,Qi WH.Management of atrial fibrillation in Chinese patients.CVD Prev Control,2009,4:79-83.
|
3. |
Gillinov AM,Gelijns AC,Parides MK,et al.Surgical ablation of atrial fibrillation during mitral-valve surgery.N Engl J Med,2015,372(15):1399-409.
|
4. |
Miragoli M,Glukhov AV.Atrial fibrillation and fibrosis:beyond the cardiomyocyte centric view.Biomed Res Int,2015,2015:798768.doi:10.1155/2015/798768.
|
5. |
Allessie M,Ausma J,Schotten U.Electrical,contractile and structural remodeling during atrial fibrillation.Cardiovasc Res,2002,54:230-246.
|
6. |
Qian YJ,Meng J,Tang H,et al.Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases.Europace,2010,12(3):371-377.
|
7. |
Li D,Fareh S,Leung TK,et al.Promotion of atrial fibrillation by heart failure in dogs:atrial remodeling of a different sort.Circulation,1999,100(1):87-95.
|
8. |
Roberts-Thomson KC,Stevenson I,Kistler PM,et al.The role of chronic atrial stretch and atrial fibrillation on posterior left atrial wall conduction.Heart Rhythm,2009,6(8):1109-1117.
|
9. |
Allessie MA,de Groot NMS,Houben RPM,et al.Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease:longitudinal dissociation.Circ Arrhythm Electrophysiol,2010,3(6):606-615.
|
10. |
Ausma J,Van der Velden HM,Lenders MH,et al.Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat.Circulation,2003,107(15):2051-2058.
|
11. |
Qian YJ,Liu Y,Tang H,et al.Circulating and local renin-angiotensinaldosterone system express differently in atrial fibrillation patients with different types of mitral valvular disease.J Renin Angiotensin Aldosterone Syst,2013,14(3):204-211.
|
12. |
Qian YJ,Shao HZ,Zhou WX,et al.Histopathological characteristics and oxidative injury secondary to atrial fibrillation in the left atrial appendages of patients with different forms of mitral valve disease.Cardiovascular Pathology,2013,22(3):211-218.
|
13. |
Qian YJ,Xiao XJ,Yuan HS,et al.Combination pharmacological cardioversion of permanent atrial fibrillation in post-prosthetic mitral valve replacement outpatients:a novel approach for the treatment of atrial fibrillation.J Int Med Res,2008,36(3):537-543.
|
14. |
Bishop JE.Regulation of cardiovascular collagen deposition by mechanical forces.Mol Med Today,1998,4(2):69-75.
|
15. |
Thomas L,Mckay T,Byth K.Abnormalities of left function after cardioversion:an atrial strain rate study.Heart,2007,93(1):89-95.
|
16. |
Prockop DJ,Kivirikko KI.Collagens:molecular biology,diseases,and potentials for therapy.Annu Rev Biochem,1995,64:403-434.
|
17. |
Reiser K,McCormick RJ,Rucker RB.Enzymatic and nonenzymatic cross-linking of collagen and elastin.FASEB J,1992,6(7):2439-2449.
|
18. |
Grau-BovéX,Ruiz-Trillo I,Rodriguez-Pascual F.Origin and evolution of lysyl oxidases.Sci Rep,2015,10568;doi:10.1038/sep10568.
|
19. |
Nave AH,MižíkováI,Niess G,et al.Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.Arterioscler Thromb Vasc Biol,2014,34(7):1446-1458.
|
20. |
Ding Z,Liu S,Deng X,et al.Hemodynamic shear stress modulates endothelial cell autophagy:Role of LOX-1.Int J Cardiol,2015,184:86-95.
|
21. |
Engebretsen KV,Lunde IG,Strand ME,Waehre A,et al.Lumican is increased in experimental and clinical heart failure,and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli.FEBS J,2013,280(10):2382-2398.
|
22. |
Magnani JW,Rienstra M,Lin H,et al.Atrial fibrillation:current knowledge and future directions in epidemiology and genomics.Circ Arrhythm Electrophysiol,2011,124(18):1982-1993.
|
23. |
López B,Querejeta R,González A,et al.Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure:potential role of lysyl oxidase.Hypertension,2012,60(3):677-683.
|
24. |
Eberson LS,Sanchez PA,Majeed BA,et al.Effect of lysyl oxidase inhibition on angiotensin Ⅱ-induced arterial hypertension,remodeling,and stiffness.PLoS One,2015,10(4):e0124013.doi:10.1371/journal.pone.0124013.
|
25. |
Qian YJ,Huanzhang S,Wenxia Z,et al.From changes in local RAAS to structural remodeling of the left atrium:A beautiful cycle in atrial fibrillation.Herz,2015,40(3):514-520.
|